Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. MRK
5. MRNA
6. ADI
7. LOW
8. COTY
9. RARE
10. TJX

Go back to Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
(NASDAQ: ABVX) Delayed: 120.56 --0 (-0%)
Previous Close $120.56    52 Week High $ 
Open $120.56    52 Week Low $ 
Day High $120.56    P/E N/A 
Day Low $120.56    EPS $ 
Volume 5,289       

(NASDAQ: ABVX) Delayed: 120.56 --0 (-0%)
Previous Close $120.56    52 Week High $ 
Open $120.56    52 Week Low $ 
Day High $120.56    P/E N/A 
Day Low $120.56    EPS $ 
Volume 5,289